Wyeth-Ayerst
Executive Summary
Licenses from University of Michigan worldwide rights to "cold-adapted" influenza virus vaccine. The modified-live virus vaccine has been developed in collaboration among researchers from U. of Michigan, NIAID, CDC and FDA and has been tested in 5,000 subjects to date.